Inhibition of expression of beta-lactamase using esters of fatty

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514546, 514547, 514558, 514560, A61K 3143, A61K 3122, A61K 31225, A61K 3120

Patent

active

054666856

ABSTRACT:
A class of chemical compounds comprising fatty acid ester derivatives used to inhibit beta-lactamase production by infectious bacteria. These inhibitors have been found to retard the resistance of certain strains of bacteria to beta-lactam antibiotics, such as penicillin, by interfering with the transcription of the beta-lactamase gene and precluding expression of beta-lactamase. In accordance therewith, these inhibitors permit effective treatment of infections of otherwise resistive bacteria with antibiotics.

REFERENCES:
Biosis Abstract of Journal of Antibiotics. (1981).
Biosis Abstract of Journal of Food Prot. (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of expression of beta-lactamase using esters of fatty does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of expression of beta-lactamase using esters of fatty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of expression of beta-lactamase using esters of fatty will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1221055

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.